Cargando…

Viral Mimicry Response Is Associated With Clinical Outcome in Pleural Mesothelioma

INTRODUCTION: The aim of this study was to investigate endogenous retrovirus (ERV) expression and type I interferon (IFN) activation in human pleural mesothelioma (PM) and their association with clinical outcome. METHODS: The expression of ERV was determined from PM cohorts and mesothelial precursor...

Descripción completa

Detalles Bibliográficos
Autores principales:	Sun, Suna, Qi, Weihong, Rehrauer, Hubert, Ronner, Manuel, Hariharan, Ananya, Wipplinger, Martin, Meiller, Clément, Stahel, Rolf, Früh, Martin, Cerciello, Ferdinando, Fonteneau, Jean-François, Jean, Didier, Felley-Bosco, Emanuela
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2022
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9709230/ https://www.ncbi.nlm.nih.gov/pubmed/36467966 http://dx.doi.org/10.1016/j.jtocrr.2022.100430

Ejemplares similares

The Pattern of RNA Editing Changes in Pleural Mesothelioma upon Epithelial-Mesenchymal Transition
por: Felley-Bosco, Emanuela, et al.
Publicado: (2023)

RNA editing in mesothelioma: a look forward
por: Hariharan, Ananya, et al.
Publicado: (2020)

Heterogeneous RNA editing and influence of ADAR2 on mesothelioma chemoresistance and the tumor microenvironment
por: Hariharan, Ananya, et al.
Publicado: (2022)

miR-625-3p and lncRNA GAS5 in Liquid Biopsies for Predicting the Outcome of Malignant Pleural Mesothelioma Patients Treated with Neo-Adjuvant Chemotherapy and Surgery
por: Kresoja-Rakic, Jelena, et al.
Publicado: (2019)

Double-Stranded RNA Structural Elements Holding the Key to Translational Regulation in Cancer: The Case of Editing in RNA-Binding Motif Protein 8A
por: Abukar, Asra, et al.
Publicado: (2021)

Identification of a seven glycopeptide signature for malignant pleural mesothelioma in human serum by selected reaction monitoring
por: Cerciello, Ferdinando, et al.
Publicado: (2013)

Non-Coding Transcript Heterogeneity in Mesothelioma: Insights from Asbestos-Exposed Mice
por: Felley-Bosco, Emanuela, et al.
Publicado: (2018)

Posttranscriptional Regulation Controls Calretinin Expression in Malignant Pleural Mesothelioma
por: Kresoja-Rakic, Jelena, et al.
Publicado: (2017)

Hedgehog Signaling in Malignant Pleural Mesothelioma
por: Felley-Bosco, Emanuela, et al.
Publicado: (2015)

Genomic landscape of pleural and peritoneal mesothelioma tumours
por: Hiltbrunner, Stefanie, et al.
Publicado: (2022)

GAS5 long non-coding RNA in malignant pleural mesothelioma
por: Renganathan, Arun, et al.
Publicado: (2014)

Expression of the Stem Cell Factor Nestin in Malignant Pleural Mesothelioma Is Associated with Poor Prognosis
por: Thies, Svenja, et al.
Publicado: (2015)

CD74: a new prognostic factor for patients with malignant pleural mesothelioma
por: Otterstrom, C, et al.
Publicado: (2014)

Hedgehog Signaling in Mesothelioma: 2019 Status
por: Felley-Bosco, Emanuela
Publicado: (2019)

Inhibition of autophagy sensitizes malignant pleural mesothelioma cells to dual PI3K/mTOR inhibitors
por: Echeverry, N, et al.
Publicado: (2015)

Special Issue on Mechanisms of Mesothelioma Heterogeneity: Highlights and Open Questions
por: Felley-Bosco, Emanuela
Publicado: (2018)

Autophagy Correlates with the Therapeutic Responsiveness of Malignant Pleural Mesothelioma in 3D Models
por: Barbone, Dario, et al.
Publicado: (2015)

Mesothelioma Driver Genes, Ferroptosis, and Therapy
por: Felley-Bosco, Emanuela, et al.
Publicado: (2019)

Exploring the Expression of the «Dark Matter» of the Genome in Mesothelioma for Potentially Predictive Biomarkers for Prognosis and Immunotherapy
por: Felley-Bosco, Emanuela
Publicado: (2023)

Live-Cell Mesothelioma Biobank to Explore Mechanisms of Tumor Progression
por: Oehl, Kathrin, et al.
Publicado: (2018)

Editorial: Moving beyond the molecular mechanisms of malignant pleural mesothelioma: Cues for novel biomarkers and drug targets
por: Cavallari, Ilaria, et al.
Publicado: (2023)

Involvement of the M-CSF/IL-34/CSF-1R pathway in malignant pleural mesothelioma
por: Blondy, Thibaut, et al.
Publicado: (2020)

Human agonistic TRAIL receptor antibodies Mapatumumab and Lexatumumab induce apoptosis in malignant mesothelioma and act synergistically with cisplatin
por: Belyanskaya, Larisa L, et al.
Publicado: (2007)

Genomic and Transcriptomic Analyses of Malignant Pleural Mesothelioma (MPM) Samples Reveal Crucial Insights for Preclinical Testing
por: Laure, Alexander, et al.
Publicado: (2023)

A Community-Driven, Openly Accessible Molecular Pathway Integrating Knowledge on Malignant Pleural Mesothelioma
por: Martens, Marvin, et al.
Publicado: (2022)

Pembrolizumab-associated minimal change disease in a patient with malignant pleural mesothelioma
por: Bickel, Angelika, et al.
Publicado: (2016)

Identification of cis- and trans-acting elements regulating calretinin expression in mesothelioma cells
por: Kresoja-Rakic, Jelena, et al.
Publicado: (2016)

Differential Effects of Lovastatin on Cisplatin Responses in Normal Human Mesothelial Cells versus Cancer Cells: Implication for Therapy
por: Shi, Yandong, et al.
Publicado: (2012)

Starvation-induced activation of ATM/Chk2/p53 signaling sensitizes cancer cells to cisplatin
por: Shi, Yandong, et al.
Publicado: (2012)

Genetic alterations of malignant pleural mesothelioma: association with tumor heterogeneity and overall survival
por: Quetel, Lisa, et al.
Publicado: (2020)

Stem Cell Factor-Based Identification and Functional Properties of In Vitro-Selected Subpopulations of Malignant Mesothelioma Cells
por: Blum, Walter, et al.
Publicado: (2017)

Malignant pleural mesothelioma
por: Rao, Sukhesh
Publicado: (2009)

Prognostic Value of EMT Gene Signature in Malignant Mesothelioma
por: Wu, Licun, et al.
Publicado: (2023)

Establishment of immortalized murine mesothelial cells and a novel mesothelioma cell line
por: Blum, Walter, et al.
Publicado: (2015)

High Oncolytic Activity of a Double-Deleted Vaccinia Virus Copenhagen Strain against Malignant Pleural Mesothelioma
por: Delaunay, Tiphaine, et al.
Publicado: (2020)

Sensitivity of human pleural mesothelioma to oncolytic measles virus depends on defects of the type I interferon response
por: Achard, Carole, et al.
Publicado: (2015)

Malignant pleural mesothelioma with resolution of pleural effusion
por: Nishida, Sayaka, et al.
Publicado: (2023)

Pleural Mesothelioma: Advances in Blood and Pleural Biomarkers
por: Sorino, Claudio, et al.
Publicado: (2023)

Editorial: Focus on malignant pleural mesothelioma immunology and immunotherapy
por: Porta, Chiara, et al.
Publicado: (2023)

The “don't eat me” signal CD47 is a novel diagnostic biomarker and potential therapeutic target for diffuse malignant mesothelioma
por: Schürch, Christian M., et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_gkqbpcnqd7o02gskoa78qh16s8